Method and system for selecting chemotherapeutic agents
AssigneeUniversity of Northern Iowa Research Foundation
InventorsLisa A. Beltz, John A. Bumpus
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Northern Iowa Research Foundation
InventorsLisa A. Beltz, John A. Bumpus
Estimating the term…
Described herein is a method and corresponding system, including reagents and assays, for determining the in vivo efficacy of drugs in the course of chemotherapy. The method can include identifying a patient having a condition, such as leukemia, that is potentially susceptible to one or more candidate drugs having a particular in vivo biochemical activity, such as the generation of reactive oxygen or nitrogen species. An in vitro biochemical assay is provided that corresponds to the biochemical activity, and a tissue sample is tested to determine the responsiveness of the tissue sample to the biochemical activity, for instance, the ability of the tissue sample to degrade or inhibit the active species (in this case, hydrogen peroxide), and thereby prevent its desired effect against the cancerous cells. A course of chemotherapy can be based, at least in part, on the responsiveness of the tissue sample to the biochemical activity.
A method for determining the in vivo efficacy of drugs in the course of chemotherapy, the method comprising the steps of:
A method of identifying a compound that inhibits cancer cells in a patient, the method comprising a) providing a patient sample, b) contacting the sample with an ROS or RNS species, at one or more concentrations, and c) determining the manner or extent to which the sample is able to degrade hydrogen peroxide, d) based on the degradation of hydrogen peroxide, determine a course of drug therapy accordingly.
A system for determining the in vivo efficacy of drugs in the course of chemotherapy, for use in prescribing drugs to a patient having a condition potentially susceptible to one or more candidate drugs having a particular in vivo biochemical activity, the system comprising an in vitro biochemical assay corresponding to the biochemical activity, and wherein the assay is adapted to be performed with a suitable tissue sample from the patient under conditions suitable to determine the responsiveness of the tissue sample to the biochemical activity, the results of which are adapted to be used for determining a course of chemotherapy based, at least in part, on the responsiveness of the tissue sample to the biochemical activity.
Dependencies are inferred from the claim text.